MedTrace Logo

Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic Use

NCT04171128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2021-03-16

No results posted yet for this study

Summary

The investigators intend to observe the inflammatory marker procalcitonin (PCT) in comparison with patient variables on morbidity, mortality and antibiotic treatment.

The overall aim is to observe if a low PCT value can have potential in reducing unessesary antibiotic use in seasonal influenza patients.

Conditions

Interventions

BEHAVIORAL

antibiotic stewardship efforts

The local antibiotic team plan to implement procalcitonin use among the hospital physicians. the interventions are not ready yet.

Sponsors & Collaborators

  • Ostfold Hospital Trust

    lead OTHER

Principal Investigators

  • Ingrid christensen, MD · Ostfold hospital trust, Kalnes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-02
Primary Completion
2020-02-14
Completion
2020-08-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171128 on ClinicalTrials.gov